PDB Short entry for 1ABN HEADER OXIDOREDUCTASE 03-SEP-92 1ABN TITLE THE CRYSTAL STRUCTURE OF THE ALDOSE REDUCTASE NADPH BINARY COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDOSE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 EC: 1.1.1.21; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION MDLTYP CA ATOMS ONLY, CHAIN A AUTHOR D.W.BORHANI,T.M.HARTER,J.M.PETRASH REVDAT 5 07-FEB-24 1ABN 1 REMARK SEQADV REVDAT 4 29-NOV-17 1ABN 1 HELIX REVDAT 3 24-FEB-09 1ABN 1 VERSN REVDAT 2 08-MAR-95 1ABN 1 HELIX REVDAT 1 31-JAN-94 1ABN 0 JRNL AUTH D.W.BORHANI,T.M.HARTER,J.M.PETRASH JRNL TITL THE CRYSTAL STRUCTURE OF THE ALDOSE REDUCTASE.NADPH BINARY JRNL TITL 2 COMPLEX. JRNL REF J.BIOL.CHEM. V. 267 24841 1992 JRNL REFN ISSN 0021-9258 JRNL PMID 1447221 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH I.TARLE,D.W.BORHANI,D.K.WILSON,F.A.QUIOCHO,J.M.PETRASH REMARK 1 TITL PROBING THE ACTIVE SITE OF ALDOSE REDUCTASE: SITE-DIRECTED REMARK 1 TITL 2 MUTAGENESIS OF ASP-43, TYR-48, LYS-77, AND HIS-110 REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 REFERENCE 2 REMARK 1 AUTH T.J.KUBISESKI,N.C.GREEN,D.W.BORHANI,T.G.FLYNN REMARK 1 TITL STUDIES ON PIG ALDOSE REDUCTASE: IDENTIFICATION OF AN REMARK 1 TITL 2 ESSENTIAL ARGININE IN THE PRIMARY AND TERTIARY STRUCTURE OF REMARK 1 TITL 3 THE ENZYME REMARK 1 REF TO BE PUBLISHED REMARK 1 REFN REMARK 1 REFERENCE 3 REMARK 1 AUTH J.M.PETRASH,T.HARTER,I.TARLE,D.BORHANI REMARK 1 TITL KINETIC ALTERATION OF HUMAN ALDOSE REDUCTASE BY MUTAGENESIS REMARK 1 TITL 2 OF CYSTEINE RESIDUES REMARK 1 REF ADV.EXP.MED.BIOL. V. 328 289 1993 REMARK 1 REFN ISSN 0065-2598 REMARK 1 REFERENCE 4 REMARK 1 AUTH J.M.PETRASH,T.M.HARTER,C.S.DEVINE,P.O.OLINS,A.BHATNAGAR, REMARK 1 AUTH 2 S.LIU,S.K.SRIVASTAVA REMARK 1 TITL INVOLVEMENT OF CYSTEINE RESIDUES IN CATALYSIS AND INHIBITION REMARK 1 TITL 2 OF HUMAN ALDOSE REDUCTASE: SITE DIRECTED MUTAGENESIS OF REMARK 1 TITL 3 CYS-80,-298 AND-303 REMARK 1 REF J.BIOL.CHEM. V. 267 24833 1992 REMARK 1 REFN ISSN 0021-9258 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : TNT REMARK 3 AUTHORS : TRONRUD,TEN EYCK,MATTHEWS REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 USING DATA ABOVE SIGMA CUTOFF. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.286 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 USING ALL DATA, NO SIGMA CUTOFF. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 301 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 WILSON B VALUE (FROM FCALC, A**2) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. RMS WEIGHT COUNT REMARK 3 BOND LENGTHS (A) : NULL ; NULL ; NULL REMARK 3 BOND ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TORSION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES (DEGREES) : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES (A) : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES (A) : NULL ; NULL ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS (A**2) : NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS (A) : NULL ; NULL ; NULL REMARK 3 REMARK 3 INCORRECT CHIRAL-CENTERS (COUNT) : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 RESTRAINT LIBRARIES. REMARK 3 STEREOCHEMISTRY : NULL REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1ABN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000170626. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 37.35500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 42.66000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 53.42000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 37.35500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 42.66000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 53.42000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 37.35500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 42.66000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 53.42000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 37.35500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 42.66000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 53.42000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 ARG A 217 REMARK 465 PRO A 218 REMARK 465 TRP A 219 REMARK 465 ALA A 220 REMARK 465 LYS A 221 REMARK 465 PRO A 222 REMARK 465 GLU A 223 REMARK 465 ASP A 224 REMARK 465 PRO A 225 REMARK 465 SER A 226 REMARK 465 LEU A 227 REMARK 465 LEU A 228 REMARK 465 GLU A 229 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NDP A 351 DBREF 1ABN A 1 315 UNP P15121 ALDR_HUMAN 1 315 SEQADV 1ABN SER A 298 UNP P15121 CYS 298 CONFLICT SEQRES 1 A 315 ALA SER ARG LEU LEU LEU ASN ASN GLY ALA LYS MET PRO SEQRES 2 A 315 ILE LEU GLY LEU GLY THR TRP LYS SER PRO PRO GLY GLN SEQRES 3 A 315 VAL THR GLU ALA VAL LYS VAL ALA ILE ASP VAL GLY TYR SEQRES 4 A 315 ARG HIS ILE ASP CYS ALA HIS VAL TYR GLN ASN GLU ASN SEQRES 5 A 315 GLU VAL GLY VAL ALA ILE GLN GLU LYS LEU ARG GLU GLN SEQRES 6 A 315 VAL VAL LYS ARG GLU GLU LEU PHE ILE VAL SER LYS LEU SEQRES 7 A 315 TRP CYS THR TYR HIS GLU LYS GLY LEU VAL LYS GLY ALA SEQRES 8 A 315 CYS GLN LYS THR LEU SER ASP LEU LYS LEU ASP TYR LEU SEQRES 9 A 315 ASP LEU TYR LEU ILE HIS TRP PRO THR GLY PHE LYS PRO SEQRES 10 A 315 GLY LYS GLU PHE PHE PRO LEU ASP GLU SER GLY ASN VAL SEQRES 11 A 315 VAL PRO SER ASP THR ASN ILE LEU ASP THR TRP ALA ALA SEQRES 12 A 315 MET GLU GLU LEU VAL ASP GLU GLY LEU VAL LYS ALA ILE SEQRES 13 A 315 GLY ILE SER ASN PHE ASN HIS LEU GLN VAL GLU MET ILE SEQRES 14 A 315 LEU ASN LYS PRO GLY LEU LYS TYR LYS PRO ALA VAL ASN SEQRES 15 A 315 GLN ILE GLU CYS HIS PRO TYR LEU THR GLN GLU LYS LEU SEQRES 16 A 315 ILE GLN TYR CYS GLN SER LYS GLY ILE VAL VAL THR ALA SEQRES 17 A 315 TYR SER PRO LEU GLY SER PRO ASP ARG PRO TRP ALA LYS SEQRES 18 A 315 PRO GLU ASP PRO SER LEU LEU GLU ASP PRO ARG ILE LYS SEQRES 19 A 315 ALA ILE ALA ALA LYS HIS ASN LYS THR THR ALA GLN VAL SEQRES 20 A 315 LEU ILE ARG PHE PRO MET GLN ARG ASN LEU VAL VAL ILE SEQRES 21 A 315 PRO LYS SER VAL THR PRO GLU ARG ILE ALA GLU ASN PHE SEQRES 22 A 315 LYS VAL PHE ASP PHE GLU LEU SER SER GLN ASP MET THR SEQRES 23 A 315 THR LEU LEU SER TYR ASN ARG ASN TRP ARG VAL SER ALA SEQRES 24 A 315 LEU LEU SER CYS THR SER HIS LYS ASP TYR PRO PHE HIS SEQRES 25 A 315 GLU GLU PHE HET NDP A 351 48 HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE FORMUL 2 NDP C21 H30 N7 O17 P3 HELIX 1 1 GLN A 26 VAL A 37 1TIM BARREL HELIX 1 12 HELIX 2 2 GLU A 51 GLU A 64 1TIM BARREL HELIX 2 14 HELIX 3 3 LYS A 85 LEU A 99 1TIM BARREL HELIX 3 15 HELIX 4 4 ILE A 137 GLU A 150 1TIM BARREL HELIX 4 14 HELIX 5 5 HIS A 163 ASN A 171 1TIM BARREL HELIX 5 9 HELIX 6 6 GLU A 193 SER A 201 1TIM BARREL HELIX 6 9 HELIX 7 7 THR A 244 ARG A 255 1TIM BARREL HELIX 7 12 HELIX 8 8 PRO A 266 PHE A 273 1TIM BARREL HELIX 8 8 HELIX 9 B SER A 282 SER A 290 1EXTRA HELIX B 9 SHEET 1 A 2 SER A 2 LEU A 5 0 SHEET 2 A 2 ALA A 10 ILE A 14 -1 SHEET 1 B 9 ILE A 14 GLY A 18 0 SHEET 2 B 9 HIS A 41 HIS A 46 1 SHEET 3 B 9 PHE A 73 LEU A 78 1 SHEET 4 B 9 ASP A 105 HIS A 110 1 SHEET 5 B 9 ALA A 155 SER A 159 1 SHEET 6 B 9 ALA A 180 ILE A 184 1 SHEET 7 B 9 VAL A 205 TYR A 209 1 SHEET 8 B 9 VAL A 258 SER A 263 1 SHEET 9 B 9 ILE A 14 GLY A 18 1 SITE 1 AC1 8 GLY A 18 TYR A 209 SER A 210 LEU A 212 SITE 2 AC1 8 SER A 214 PRO A 261 LYS A 262 SER A 263 CRYST1 74.710 85.320 106.840 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 0.013385 0.000000 0.000000 0.00000 ORIGX2 0.000000 0.011721 0.000000 0.00000 ORIGX3 0.000000 0.000000 0.009360 0.00000 SCALE1 0.013385 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011721 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009360 0.00000